One in five pregnant women carry Streptococcus agalactiae (group B strep or GBS) in the vaginal tract, which is typically harmless—except when it isn't.
Nov 22, 2023
0
0
Researchers at Michigan State University may have discovered why visceral pain is so common in people who have experienced inflammation in their guts, including patients with irritable bowel syndrome, or IBS.
Nov 21, 2023
0
43
Unstable housing before starting dialysis is associated with an increased risk for all-cause mortality among veterans receiving dialysis, according to a study published online Nov. 21 in JAMA Network Open.
Nov 21, 2023
0
0
Development of potential or improved anti-cancer treatments is being blocked or slowed down by a lack of transparency in data sharing between pharmaceutical companies and research groups, according to cancer clinicians, researchers ...
Nov 21, 2023
0
0
Antimicrobial resistance is one of the biggest global threats to health, food security and development. This month, The Conversation's experts explore how we got here and the potential solutions.
Nov 21, 2023
0
0
Very few patients with psoriasis are depicted in scientific articles—only a fraction of those included in the research are represented in images. This is revealed by a study from the University of Gothenburg, Sweden, together ...
Nov 20, 2023
0
0
In updated guidelines issued by the American Academy of Dermatology and published online Nov. 7 in the Journal of the American Academy of Dermatology, recommendations are presented for use of phototherapy and systemic therapies ...
Nov 16, 2023
0
0
Britain's medicines regulator has authorized the world's first gene therapy treatment for sickle cell disease, in a move that could offer relief to thousands of people with the crippling disease in the U.K.
Nov 16, 2023
0
1
Major work led by Dr. André Veillette's team at the Institut de recherches cliniques de Montréal (IRCM), in collaboration with a group of researchers, and just published in Nature Immunology, managed to identify a previously ...
Nov 16, 2023
0
493
The addition of pembrolizumab to standard platinum-pemetrexed chemotherapy results in significant improvement in overall survival among patients with advanced pleural mesothelioma, according to a study published online Nov. ...
Nov 15, 2023
0
0
